Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Amide. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN118880359B reveals a green electrochemical route for alpha-ketoamide derivatives, offering cost reduction in pharmaceutical intermediate manufacturing and enhanced supply chain reliability.
Patent CN111116581A details a green one-pot synthesis for 2,9-diamide-1,10-phenanthroline compounds, offering significant cost reduction and improved purity for radiochemical applications.
Novel synthesis of 2-cyclopropyl-1-(2-fluorophenyl)-2-carbonyl ethyl p-toluenesulfonate via Weinreb amide. High yield, low cost, scalable process for API manufacturing.
Patent CN112194633B reveals a novel one-pot copper-catalyzed route for Apalutamide intermediates, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturing.
Patent CN101585763B reveals a high-yield synthesis route for fexofenadine intermediates, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturers.
Patent CN101585782B reveals a high-yield synthesis for Fexofenadine intermediates, offering significant cost reduction and simplified purification for pharmaceutical manufacturing.
Patent CN101585768B details a high-yield route for 2-[4-(4-chlorobutyryl)phenyl]-2-methylpropanoate. Eliminates meta-isomers for superior supply chain reliability.
Novel FeCl3-catalyzed reduction method for high-purity 2-aminopyrimidine compounds, eliminating toxic iron sludge and difficult impurities for scalable API manufacturing.
Patent CN102070581B details a catalyst-free hydrolysis for dronedarone intermediates, offering cost reduction and scalable supply chain solutions for global pharmaceutical manufacturing.
Novel toluene-based process for nefopam intermediate I ensures high purity and reduced toxicity. Ideal for reliable pharmaceutical intermediate suppliers seeking cost reduction.
Novel patent CN105061245A details moderate conditions for Safinamide. Offers supply chain reliability and cost reduction in API manufacturing.
Patent CN1732149A details a scalable Claisen rearrangement for 3,3a,6,6a-tetrahydro-2H-cyclopenta[b]furan-2-one, offering cost reduction and high purity for pharmaceutical manufacturing.
Patent CN111606820B reveals a metal-free route for N-iodobenzene-N-phenylamides using m-CPBA, offering cost-effective and green manufacturing solutions for pharma intermediates.
Patent CN111606820B reveals a metal-free route for N-iodobenzene-N-phenylamides using m-CPBA. This method offers significant cost reduction and supply chain reliability for pharma manufacturing.
Patent CN107428695B details a scalable Suzuki coupling for 2-chloro-4-(1H-pyrazol-3-yl)benzonitrile, reducing palladium usage and simplifying workup.
Patent CN106946935B reveals a high-yield method for diastereoisomeric nucleoside derivatives, offering significant cost reduction in API manufacturing and scalable supply chain solutions.
Patent CN106946935B reveals a high-yield thermal isomerization process for Tenofovir Alafenamide intermediates, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturers.
Novel solvent-free esterification route for Tenofovir Alafenamide impurity TAF-Y ensures >98% purity and scalable manufacturing for pharma reference standards.
Patent CN103159672A details a novel tropicamide preparation using phenyl ethyl malonate, offering cost reduction in pharmaceutical manufacturing and improved supply chain reliability.
Patent CN103059048A details a novel BSA-mediated silylation method for Cefpiramide acid, offering superior purity and homogeneous reaction conditions for pharmaceutical manufacturing.